EraGen Again Moving Multiplex Assays Toward Clinic in Wake of Luminex Separation
May 27, 2010
EraGen Again Moving Multiplex Assays Toward Clinic in Wake of Luminex Separation
Following the dissolution last year of a longstanding relationship with Luminex, EraGen is once again eyeing the IVD market for its multiplex PCR assay reagents by partnering with other companies offering bead-based detection systems.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.